New support to help vulnerable countries tackle Omicron

Download logo

Foreign Minister Liz Truss has pledged up to £ 105m in UK emergency assistance to help vulnerable countries work on the Omicron Covid-19, with a particular focus on Africa.

Important assistance is provided through a trusted partner and does the following:

  • Scale-up testing – especially in parts of Africa with the lowest test rates for Covid-19 – enables healthcare systems to more effectively track and respond to the spread of the virus. This adds to the support for the UK’s world-leading genomic sequence.
  • Improving access to the oxygen supply to the ventilator – surges in oxygen demand are a significant risk for some countries.
  • It provides the community with hygiene advice, products, access to hand-washing facilities and supports thorough cleaning in schools, health centers and other public places. It is based on a successful global hygiene campaign between UK aid and Unilever, which has reached more than 1.2 billion people since its inception in 2020.
  • It will fund breakthrough science in the UK and research into the dissemination of variants such as Omicron, enabling innovative evidence-based policy responses in low- and middle-income countries.
  • Prepare the UK’s own expert emergency team to expand overseas to critical hotspots, including new medical equipment.

The government also confirmed that more than 30 million vaccines have been provided so far as part of the UK’s commitment to donate 100 million doses to the world and benefit more than 30 countries.

Foreign Minister Liz Truss said:

“The UK is providing significant support in tackling the spread of new variants around the world. This is the key to ensuring our freedom and ending this pandemic altogether.

“We are proud to have provided more than 30 million vaccines to benefit our friends around the world this year. The UK is helping other countries in the most need. Everyone is safe. No one is safe until

The dose donated by the United Kingdom has reached four continents and provides significant protection from Covid-19 in countries such as Angola, Cambodia, the Democratic Republic of the Congo, Ethiopia, Ghana, Indonesia, Malawi, Nepal and Rwanda.

Of the more than 30 million doses currently donated, 24.6 million were received by COVAX for delivery to the country and 5.5 million were shared directly with needy countries such as Kenya, Jamaica and Indonesia. I am.

In 2022, millions more vaccines will be sent to other countries, including 20 million doses of Oxford-AstraZeneca and 20 million doses of Janssen.

The United Kingdom has been at the forefront of the global response to Covid-19. Today’s announcement is based on £ 1.3 billion in UK aid to tackle international health care early in the pandemic and support vaccines, health systems and economic recovery in developing countries.

The government has also invested more than £ 88 million to support the development of the Oxford-AstraZeneca vaccine, making the UK the first country in the world to approve jabs a year ago today.

Thanks to AstraZeneca’s commitment, the vaccine has been distributed on a non-profit basis, with 2.5 billion doses in more than 170 countries, two-thirds of which are low- and middle-income countries.

Sajid Javid, Minister of Health, said:

“The pandemic has challenged the healthcare system around the world. The best way to overcome this terrible illness is to stand side by side with international partners.

“Supporting the country with UK breakthrough science and research on the epidemic of variants, improving access to oxygen, and scaling up tests to help the most needy people get out of the pandemic. To do.

“We are proud to have already delivered more than 30 million vaccines to our overseas friends. As a global leader, we are helping other countries in the most need. Everyone is safe. Until then, no one is safe. “

Dr. Seth Berkley, CEO of the Vaccine Alliance Gavi, said:

“We especially welcome the UK’s commitment to new funding to protect the most vulnerable people in Africa. The UK has an early funding commitment at UNGA 2020 and the Prime Minister’s commitment to G7 dose sharing ( Through achieving the 30 million target set by the end of 2021), we continue to focus on equitable global access to COVAX and COVID 19 vaccines.

“We look forward to being able to operate the rest of the UK’s dose sharing commitments through COVAX in 2022, and in collaboration with the UK government, the UK’s largest funder, Gavi. We will continue to support the ambitious 2021-2025 routine vaccine program. The Prime Minister’s commitment at the UK-sponsored Global Vaccine Summit in June 2020. “

Distributed by the APO Group on behalf of the UK Government.

New support to help vulnerable countries tackle Omicron

Source link New support to help vulnerable countries tackle Omicron

Back to top button